Scopus Atıf Havuzu

Novel insights into corema album berries: Vibrational profile and biological activity

Essential oil extraction from fresh needles of Pinus pumila (Pall.) Regel using a solvent-free microwave-assisted methodology and an evaluation of acetylcholinesterase inhibition activity in vitro compared to that of its main components

Leveraging publicly available coronavirus data to identify new therapeutic targets for COVID-19

Baseline Neutrophil-to-Lymphocyte Ratio Is Independently Associated With 90-Day Transplant-Free Mortality in Patients With Cirrhosis

Host Genetics and Antiviral Immune Responses in Adult Patients With Multisystem Inflammatory Syndrome

New Variant with a Previously Unrecognized Mechanism of Pathogenicity in Hypertrophic Cardiomyopathy

Host Genetics and Antiviral Immune Responses in Adult Patients With Multisystem Inflammatory Syndrome

Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study

COVID-19 Immunobiology: Lessons Learned, New Questions Arise

Emerging technologies for conversion of sustainable algal biomass into value-added products: A state-of-the-art review

Simple and effective removal of psychiatric pharmaceuticals from wastewater treatment plant effluents by magnetite red mud nanoparticles

One Hundred Years of Hybrid Necrosis: Hybrid Autoimmunity as a Window into the Mechanisms and Evolution of Plant-Pathogen Interactions

Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome

Hematoma Expansion Shift Analysis to Assess Acute Intracerebral Hemorrhage Treatments

SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients

The early interferon catches the SARS-CoV-2

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths